Dopamine Beta-hydroxylase Deficiency
📧 Sign up to get email alerts when something new happens for Dopamine Beta-hydroxylase Deficiency.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-03-02Clinical Trial Update: Treatment of Orthostatic Hypotension [Phase 2, Phase 3]
Phase 2/3 trial update for treatment of orthostatic hypotension; study terminated with results posted.
-
CLINICAL_TRIALS approval · 2016-10-18Clinical Trial Update: Long Term Treatment With L-DOPS
Regulatory update announcing marketing approval of L-DOPS (droxidopa) for Dopamine beta-hydroxylase deficiency. This marks the availability …
-
CLINICAL_TRIALS trial_result · 2016-01-08Clinical Trial Update: A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy [Phase 3]
Phase 3 study of droxidopa in symptomatic neurogenic orthostatic hypotension, including participants with Parkinson's disease, multiple syst…
-
CLINICAL_TRIALS trial_result · 2014-05-20Clinical Trial Update: Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) [Phase 3]
This update reports the Phase 3 results of droxidopa in patients with symptomatic neurogenic orthostatic hypotension.
-
CLINICAL_TRIALS trial_result · 2014-05-16Clinical Trial Update: A Clinical Study for Patients With Neurogenic Orthostatic Hypotension (NOH) Using Droxidopa [Phase 3]
Phase 3 clinical trial of droxidopa for neurogenic orthostatic hypotension has completed; results have been posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-05-16Clinical Trial Update: Open-Label Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) [Phase 3]
Open-label Phase 3 study of droxidopa in neurogenic orthostatic hypotension has completed and results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-04-21Clinical Trial Update: Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) (Droxi-304) [Phase 3]
Phase 3 clinical study of droxidopa (NOH) completed; results posted in 2014 for patients with neurogenic orthostatic hypotension and related…